ADMA BIOLOGICS INC has a total of 24 patent applications. It increased the IP activity by 266.0%. Its first patent ever was published in 2015. It filed its patents most often in United States, Israel and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are GENAGON THERAPEUTICS AB, EUCURE BEIJING BIOPHARMA CO LTD and ALLAKOS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | Israel | 3 | |
#3 | Australia | 2 | |
#4 | Brazil | 2 | |
#5 | Mexico | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Canada | 1 | |
#8 | EPO (European Patent Office) | 1 | |
#9 | Hong Kong | 1 | |
#10 | Republic of Korea | 1 | |
#11 | Singapore | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Environmental technology | |
#5 | Computer technology | |
#6 | Audio-visual technology |
# | Name | Total Patents |
---|---|---|
#1 | Grossman Adam S | 15 |
#2 | Mond James | 15 |
#3 | Grossman Jerrold B | 7 |
#4 | Goldstein Dov A | 7 |
#5 | Adam S Grossman | 4 |
#6 | James Mond | 4 |
#7 | Pinkert Adam | 2 |
#8 | Ishay Amir Ben | 2 |
#9 | Jerrold B Grossman | 2 |
#10 | Holtzberg Moshe | 2 |
Publication | Filing date | Title |
---|---|---|
US2021034720A1 | Automated document management system | |
WO2021021122A1 | Automated document management system | |
US2018265574A1 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | |
US2016114037A1 | Compositions and methods for the treatment of immunodeficiency |